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In the previous issue of Critical Care, Cohen and 
colleagues [1] conducted a feasibility study and examined 
10 burn patients and 3 healthy volunteers to determine 
whether there were correlations between tissue cortisol 
levels and plasma-free cortisol levels. Th  e  authors 
hypothesized that tissue cortisol levels are more relevant 
as this is what binds to cellular cortisol receptors and 
leads to cortisol-associated physiological changes seen. 
Th  e authors concluded that obtaining tissue cortisol 
levels was feasible, but there was no correlation between 
tissue and plasma cortisol levels.
Diﬀ   erent methods of measuring cortisol levels are 
used. Th  e most commonly used method measures total 
serum cortisol, which is free and protein (transcortin and 
albumin)-bound cortisol. Measuring total cortisol has 
poor sensitivity and speciﬁ   city and high variability in 
critically ill patients [2]. In addition, the immunoassays 
used to determine total cortisol are subject to inter-
ference, with heterophile antibodies present in some 
critically ill patients [3]. Using mass spectroscopy to 
measure cortisol is more speciﬁ   c though not widely 
available. Some have suggested using ratios like the free 
cortisol index [4] to calculate the free cortisol amount; 
however, these methods do not account for all proteins 
such as albumin, they require measurement of 
transcortin (a lab test not widely available), and they do 
not adequately account for any dilutional eﬀ  ects  of 
massive resuscitation or of other hormonal changes (for 
example, vasopressin) that may aﬀ   ect plasma cortisol 
levels [5]. Cosyntropin stimulation testing has been 
advocated by some [6-8] to determine whether there is 
relative adrenal insuﬃ   ciency; however, the values used as 
a standard for ‘inadequate response’ were determined in 
healthy adults (not critically ill patients), and there is still 
a high level of variability in measurements, even in the 
same patient [9,10]. Th  e most accurate active cortisol 
measure that is clinically relevant is serum-free cortisol 
[9,11]. Measuring serum-free cortisol, however, is very 
diﬃ   cult to perform and thus is not widely available. A 
widely available and less costly test that does correlate 
well with plasma-free cortisol levels is to measure salivary 
cortisol levels [12]. However, it is diﬃ     cult to get an 
adequate saliva sample in critically ill patients [13].
Th   e study of Cohen and colleagues [1] is one of the ﬁ  rst 
to examine tissue cortisol levels. Although measuring 
tissue cortisol may be more pathophysiologically relevant 
than measuring plasma levels, it is not clear how 
measuring cortisol levels in tissues relates to relevant 
outcomes of decreased vasopressor use and improved 
mortality. Th  ere have been many studies examining 
plasma cortisol levels and relating them, or treatment of 
relative adrenal insuﬃ     ciency, with relevant outcomes 
[6,7]. To our know  ledge, there are no studies linking 
tissue cortisol levels to relevant outcomes. It is known 
that there is tissue resis  tance to glucocorticoids, 
potentially due to local cyto  kine production leading to 
downregulation and decreased aﬃ   nity of glucocorticoid 
receptors and post-receptor alterations [14]. Th  us, 
cortisol levels may be very diﬀ  erent in diﬀ  erent tissues, 
raising the question of what tissue the cortisol should be 
measured in. With massive resusci  tation, tissues can also 
become very edematous and this may dilute tissue 
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The importance of adrenal function to survival in 
critically ill patients has been established; however, 
identifying the best method to diagnose adrenal 
insuffi   ciency has been problematic. Multiple methods 
of determining adrenal function have been developed, 
each with its advantages and disadvantages. 
Serum-free cortisol levels are probably the most 
accurate, although obtaining this result is technically 
demanding. Cohen and colleagues investigated the 
feasibility of measuring tissue cortisol levels in burn 
patients and whether tissue cortisol levels could be 
used as a surrogate for plasma-free cortisol levels.
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© 2010 BioMed Central Ltdcortisol levels, again raising the ques  tions of when to 
obtain tissue cortisol levels, where to obtain the levels, 
and the accuracy of the result. Cortisol has eﬀ  ects on 
gluconeogenesis, vascular tone, endothelial integrity, and 
angiotensinogen synthesis and has anti-inﬂ  ammatory 
eﬀ  ects on the immune system [15]. All of these eﬀ  ects of 
cortisol aﬀ   ect the entire organism, suggesting that 
measuring circulating cortisol, rather than tissue cortisol, 
may be more relevant and useful from a clinical point of 
view. Eﬀ  orts should continue to determine more eﬃ   cient 
and eﬀ  ective ways to measure serum-free cortisol levels 
or related markers so that these assays can be widely used 
in a way that can beneﬁ   t critically ill patients in the 
intensive care unit.
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